1-tert-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate hydrochloride

Catalog No. :
ACZQKC775
CAS No. :
2197615-60-2
Molecular Formula :
C13H25ClN2O4
Molecular Weight :
308.81

IUPAC Name:1-(tert-butyl) 3-ethyl 4-aminopiperidine-1,3-dicarboxylate hydrochloride

1-tert-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$117.00Login to see priceInquiryInquiry
250mg95%$166.00Login to see priceInquiryInquiry
1g95%$430.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-tert-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate hydrochloride
IUPAC Name1-(tert-butyl) 3-ethyl 4-aminopiperidine-1,3-dicarboxylate hydrochloride
MDL No.MFCD30737899
Molecular FormulaC13H25ClN2O4
Molecular Weight308.81
SMILESO=C(OC(C)(C)C)N1CCC(N)C(C(=O)OCC)C1.[H]Cl
InChI KeyNNPKWYFUVKCVAY-UHFFFAOYSA-N
Synonym1-Boc-4-amino-piperidine-3-carboxylic acid ethyl ester hydrochloride
CAS No.2197615-60-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACZQKC775 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMJW324 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACZQKC775 route product structure diagram
    ACZQKC7752197615-60-2
Inquiry

2. ACZQKC775 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMJW324 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACZQKC775 route product structure diagram
    ACZQKC7752197615-60-2
Inquiry

Comments (0)